TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers examining donated brain tissue found that immature neurons were present in people with and without Alzheimer’s dementia, including cognitively resilient older adults. The resilient group showed different activity in these rare cells, including signals associated with survival and lower inflammation and cell death; the study does not establish that the cells cause protection or that new neurons are being formed.
Researchers at the Netherlands Institute for Neuroscience have reported that rare immature neurons in donated brain tissue showed different activity patterns in people who remained cognitively sharp despite Alzheimer’s-related brain changes. The findings point to a possible cellular clue to cognitive resilience, but do not show that these cells prevent dementia or that they are newly formed neurons.
The team compared brain tissue from three groups: people without detectable brain pathology, people who had Alzheimer’s dementia, and people whose brains showed Alzheimer’s pathology but who had not developed dementia. Researchers focused on a small region within the brain’s memory center, which is considered a possible site of adult neurogenesis. The tissue was obtained through the Netherlands Brain Bank.
Immature neurons appeared in all three groups, including among older adults whose average age was over 80, according to senior author Evgenia Salta. The researchers initially expected resilient people to have substantially more of these cells. Instead, the difference in cell numbers was smaller than expected, shifting attention to how the cells behaved rather than how many were present.
In the resilient group, the cells showed activity associated with survival and protection from damage, alongside lower signals related to inflammation and cell death. The team said this pattern could mean immature neurons help support nearby brain tissue, rather than serving only as replacements for damaged cells. The study reports biological associations in brain samples; it does not establish a cause-and-effect relationship.
A Possible Cellular Route to Resilience
Alzheimer’s research often focuses on the disease processes linked to damage and worsening memory and thinking. This study highlights a different question: why do some people retain cognitive abilities despite signs of disease in the brain? A better account of that difference could eventually help researchers identify ways to support brain function, though the findings are an early step rather than a treatment result.
The reported activity patterns suggest that cell survival and the surrounding tissue environment may matter alongside the number of immature neurons. If further work confirms that interpretation, it could broaden research into resilience beyond whether the brain can replace lost cells. The study does not show that immature neurons can be stimulated safely or effectively in patients, or that changing their activity would delay dementia.
Salta told ScienceDaily that roughly 30 percent of older adults with Alzheimer’s disease do not experience its symptoms. That figure is part of her explanation of the research question; the supplied report does not provide the underlying population study or further detail on how the estimate was calculated.
Products Worth Considering
Philips Sonicare DiamondClean 9500 Electric Toothbrush with 3 Brush Heads – Black
Levoit Vital Pet Pro Smart Air Purifier for Pets, White
Garmin Forerunner 70 GPS Running Smartwatch, 43 mm, Black
As an affiliate, we earn on qualifying purchases.
How Researchers Searched for Rare Cells
Adult neurogenesis means the production of new neurons in an adult brain. It has been documented in several animal species, but whether it continues in the adult human brain has been debated for decades. The presence of immature-looking cells alone does not prove that they were recently produced: researchers would need evidence that distinguishes newly formed neurons from cells that remain immature for other reasons.
That uncertainty shaped the team’s approach. Salta said the cells were extremely rare, so the researchers developed methods to examine the specific brain location where they expected to find them and to identify the cells without relying heavily on assumptions from animal studies. The comparison between dementia, resilience and control groups then allowed the team to look for differences in cell abundance and activity.
The work builds on a broader effort to understand why brain pathology and cognitive symptoms do not always align. In this study, the key contrast was between people with Alzheimer’s-related pathology who developed dementia and those who remained cognitively resilient. The report does not provide the number of donors, detailed clinical measures, or full methods needed to assess the study’s scope.
“Around 30 percent of older adults who develop Alzheimer’s disease never experience its symptoms. We really don’t know why. That’s a big mystery, and a very important one.”
— Evgenia Salta, senior author, quoted by ScienceDaily
What the Brain Samples Cannot Show
The findings do not determine whether immature neurons in the human brain are newly generated, how they might affect neighboring cells, or whether their activity helps preserve cognition. The report describes associations in donated tissue, which cannot by itself show that one biological pattern caused a person to resist dementia symptoms.
Details needed to judge the reach of the results—including the number of tissue donors, the study’s full statistical analysis and whether the findings have been independently replicated—are not included in the supplied report. It is also unclear whether the activity patterns are specific to resilience or reflect other differences between the groups.
Finally, the report does not identify a treatment based on the findings. Any suggestion that immature neurons could be targeted to protect cognition remains a research possibility, not a demonstrated clinical benefit.
Testing the Resilience Signal Further
The next research steps will need to test whether the cell-activity differences hold in larger and independent groups, and to clarify what the signals mean biologically. Researchers will also need ways to determine whether the cells are newly produced and to examine how they interact with surrounding tissue over time.
Further studies could investigate whether the patterns seen in donated brains can be linked to cognitive outcomes using other methods, and whether similar processes can be studied in living people. The report does not announce a timetable, a follow-up trial or a planned treatment study. For now, the finding is a potential research lead that may help explain resilience, not evidence that Alzheimer’s dementia can be prevented by activating immature neurons.
Key Questions
What did the researchers find?
They found immature neurons in brain samples from people without detectable pathology, people with Alzheimer’s dementia, and people with Alzheimer’s pathology who remained cognitively resilient. In the resilient group, these cells showed activity associated with survival and lower signals related to inflammation and cell death.
Does the study prove that immature neurons prevent Alzheimer’s symptoms?
No. The study reports differences in donated brain tissue, not proof that immature neurons caused people to remain cognitively sharp. The findings point to a possible association that needs further testing.
Does finding immature neurons prove the adult brain makes new neurons?
No. The presence of immature-looking cells does not by itself establish that they were recently formed. Whether adult human brains continue to produce new neurons remains a subject of scientific debate.
Could this finding lead to a treatment?
The result may guide future research into brain resilience, but the report describes no treatment or clinical benefit. Researchers would need to confirm the findings and establish whether changing these cells’ activity is possible and safe before drawing treatment conclusions.
Source: sciencedaily.com
